Fierce Pharma

Abivax has appointed Michael Nesrallah as its chief commercial officer, [...]

The FDA this month issued a warning letter to ImmunityBio [...]

Gilead increased CEO Daniel O’Day’s compensation by 20% in 2025, [...]

Insmed has revealed results from a trial of Arikayce, which [...]

A pair of rivals developing drugs for common retinal diseases [...]

With patents expiring today in India for Novo Nordisk’s popular [...]

Not long after lending its support to a documentary aimed [...]

The status of the CDC’s vaccine advisory panel was thrown [...]

The new FDA nod makes Rhythm Pharma’s Imcivree the first [...]

The company is working with regulators to ensure stable ongoing [...]